Pharma giant Eli Lilly and Company is collaborating with chip maker NVIDIA to build a supercomputer to manage data ingestion, training, fine-tuning and high-volume inference to enhance drug discovery.

Nvidia CEO Jensen Huang speaks during the Live Keynote Pregame during the Nvidia GTC (GPU Technology Conference) in Washington, D.C., on Oct. 28, 2025. (Photo by JIM WATSON/AFP via Getty Images) ...

Forbes contributors publish independent expert analyses and insights. Marco Chiappetta is a technologist who covers semiconductors and AI. Over the last few days, the U.S. Department of Energy (DOE) ...

During CES 2025, NVIDIA spent much of its keynote touting its leading position in artificial intelligence. Still, the company managed to squeeze in a few notable hardware announcements, including its ...

At NVIDIA’s GTC conference in Washington, DC, today, the company released a raft of news. Here’s a round-up with links to the full releases: NVQLink — Connecting Quantum and GPU Computing for 17 ...

Nvidia's new platform aims to reduce the cost of training LLMs. It uses six AI chips to lower token costs and GPU requirements. The first platforms will roll out to partners later in the year. The ...

Installation of NVQLink-enabled Sqale quantum computer announced at Illinois Quantum & Microelectronics Park Until now, there hasn't been a single, unified interface for supercomputing centers and ...

Causal artificial intelligence startup Alembic Technologies Inc. said today it has raised $145 million in a Series B growth round that increases its valuation almost 16-fold. It’s using a big chunk of ...